Telerehabilitation After Coronavirus

COVID Clinical Trial

Official title:

Telerehabilitation After Covid-19: Effectiveness of Respiratory and Aerobic Training

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04473898
• Other study ID #: KaratayU2
• Status: Completed
• Phase: N/A
• Start date: June 19, 2020
• Est. completion date: February 17, 2021

Study information

• Verified date: July 2020
• Source: KTO Karatay University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The aim of the study is to investigate the effects of telerehabilitation program on COVID-19 symptoms, quality of life, level of depression, perception of dyspnea, sleep, fatigue, kinesiophobia and patient satisfaction in individuals diagnosed with COVID-19.

Description:

Because of the risk of infection, telerehabilitation applications are recommended for patients with COVID-19. There are no studies in the literature evaluating the effectiveness of telerehabilitation program after COVID-19. In particular, the importance of the first eight weeks after the disease was emphasized.

It is thought that the telerehabilitation program will improve the functional capacities and quality of life of patients in order to adapt to the daily life after the infection more easily, to cope with the symptoms brought about by the disease more easily and to prevent the respiratory distress, intensive care stay and inactivity due to muscle weakness.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 35
• Est. completion date: February 17, 2021
• Est. primary completion date: October 19, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 25 Years to 70 Years

Eligibility

Inclusion Criteria:

• volunteering to participate in the study

• at least once diagnosed with COVID-19,

• has a cognitive level that can adapt to online exercises,

• having a physical condition suitable for exercises

• staying in hospital due to covid-19

Exclusion Criteria:

• refuse to participate in the study

• having neurological, cardiac, respiratory disease that prevents exercise

Related Conditions & MeSH terms

• COVID

Intervention

Other:
• Aerobic Exercise Training
Aerobic exercises using all body muscles and that one can do on their own after being shown online

Behavioral:
• Patient Education
Patient education about covid-19 and hygiene education

Other:
• Respiratory Exercise Training
Respiratory exercises that one can do on their own after being shown online

Locations

Country	Name	City	State
Turkey	KTO Karatay University	Konya	Karatay

Sponsors (1)

Lead Sponsor	Collaborator
KTO Karatay University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Dyspnoea	It will be evaluated by the Modified Medical Research Council (mMRC). It consists of 5 items between 0 and 4. The increase in the score indicates the severity of dyspnea.	baseline
Primary	Anxiety and Depression	It will be evaluated by the Hospital Anxiety and Depression Scale (HADS). The questionnaire comprises seven questions for anxiety and seven questions for depression, and takes 2-5min to complete. Although the anxiety and depression questions are interspersed within the questionnaire, it is vital that these are scored separately. Cut-off scores are available for quantification, for example a score of 8 or more for anxiety. The increase in the score indicates the severity of anxiety and depression.	baseline
Primary	Sleep Quality	It will be evaluated by pittsburgh sleep quality index	baseline
Primary	Health Related Quality of Life	It will be evaluated by SF-36	baseline
Primary	Dyspnoea	It will be evaluated by the Modified Medical Research Council (mMRC). It will be evaluated by the Modified Medical Research Council (mMRC). It consists of 5 items between 0 and 4. The increase in the score indicates the severity of dyspnea.	6 weeks later
Primary	Anxiety and Depression	It will be evaluated by the Hospital Anxiety and Depression Scale (HADS). The questionnaire comprises seven questions for anxiety and seven questions for depression, and takes 2-5min to complete. Although the anxiety and depression questions are interspersed within the questionnaire, it is vital that these are scored separately. Cut-off scores are available for quantification, for example a score of 8 or more for anxiety. The increase in the score indicates the severity of anxiety and depression.	6 weeks later
Primary	Sleep Quality	It will be evaluated by pittsburgh sleep quality index	6 weeks later
Primary	Health Related Quality of Life	It will be evaluated by SF-36	6 weeks later
Secondary	Kinesiophobia	It will be evaluated by Kinesiophobia Causes Scale. The questionnaire consist of 20 closed questions, assessed in a range from 0 to 100 - a higher score indicating a higher fear of movement	baseline
Secondary	Patient Satisfaction	It will be evaluated by patient satisfaction scale. Likert scale questionnaire proposed seven dimensions of patient satisfaction directed toward their doctors. These are general satisfaction, technical quality, interpersonal manner, communication, financial aspects, time spent with doctor, and accessibility and convenience. Increased score indicates decreased satisfaction. The minimum score is 18, the maximum score is 90.	6 weeks later
Secondary	Fatigue	It will be evaluated by Fatigue Severity Scale. A self-report scale of nine items about fatigue, its severity and how it affects certain activities. Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree. This means the minimum score possible is nine and the highest is 63.	baseline
Secondary	Kinesiophobia	It will be evaluated by Kinesiophobia Causes Scale. The questionnaire consist of 20 closed questions, assessed in a range from 0 to 100 - a higher score indicating a higher fear of movement	6 weeks later
Secondary	Fatigue	It will be evaluated by Fatigue Severity Scale. A self-report scale of nine items about fatigue, its severity and how it affects certain activities. Answers are scored on a seven point scale where 1 = strongly disagree and 7 = strongly agree. This means the minimum score possible is nine and the highest is 63.	6 weeks later